GrayMatters Health

GrayMatters Health (GMH), founded by Rani Cohen, Shai Attia, and Oded Kraft, is a company that develops digital self-neuromodulation therapies for mental disorders, helping patients regain the ability to regulate emotions. GMH offers Prism, the first digital therapeutic device for treating PTSD. Prism is used for treating post-traumatic stress disorder (PTSD) and is currently undergoing clinical studies at five sites in the United States and Israel to demonstrate its efficacy and safety as an adjunct therapy to standard PTSD treatments. This new technology was developed by Professor Talma Hendler and her team from Tel Aviv Sourasky Medical Center and Tel Aviv University.